+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sulphonamides Market 2024-2028

  • PDF Icon

    Report

  • 140 Pages
  • July 2024
  • Region: Global
  • TechNavio
  • ID: 5639399
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The sulphonamides market is forecasted to grow by USD 123.4 million during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the sulphonamides market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of infectious diseases, rising urinary tract infections among individuals, and special regulatory designations.

The sulphonamides market is segmented as below:

By Formulation

  • Oral
  • Topical

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa
This study identifies the growing awareness of various diseases and their treatment as one of the prime reasons driving the sulphonamides market growth during the next few years. Also, strategic alliances and mergers and acquisitions (M&A) and increased federal and institutional funding for antibiotic research will lead to sizable demand in the market.

The report on the sulphonamides market covers the following areas:

  • Sulphonamides market sizing
  • Sulphonamides market forecast
  • Sulphonamides market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sulphonamides market vendors that include AA Pharma Inc., Abbott Laboratories, Agron Remedies Pvt. Ltd., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Cipla Inc., Dhanuka Agritech Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Lexine Technochem Pvt. Ltd., Novartis AG, PANPHARMA S.A., Pfizer Inc., Sanofi SA, Smilax Laboratories Ltd., Stedman Pharmaceuticals Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd. Also, the sulphonamides market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Formulation
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Sulphonamides Market 2018 - 2022
Historic Market Size - Data Table on Global Sulphonamides Market 2018 - 2022 ($ million)
4.2 Formulation segment analysis 2018 - 2022
Historic Market Size - Formulation Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Formulation
6.1 Market segments
Chart on Formulation - Market share 2023-2028 (%)
Data Table on Formulation - Market share 2023-2028 (%)
6.2 Comparison by Formulation
Chart on Comparison by Formulation
Data Table on Comparison by Formulation
6.3 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.4 Topical - Market size and forecast 2023-2028
Chart on Topical - Market size and forecast 2023-2028 ($ million)
Data Table on Topical - Market size and forecast 2023-2028 ($ million)
Chart on Topical - Year-over-year growth 2023-2028 (%)
Data Table on Topical - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Formulation
Market opportunity by Formulation ($ million)
Data Table on Market opportunity by Formulation ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 APAC - Market size and forecast 2023-2028
Chart on APAC - Market size and forecast 2023-2028 ($ million)
Data Table on APAC - Market size and forecast 2023-2028 ($ million)
Chart on APAC - Year-over-year growth 2023-2028 (%)
Data Table on APAC - Year-over-year growth 2023-2028 (%)
8.6 South America - Market size and forecast 2023-2028
Chart on South America - Market size and forecast 2023-2028 ($ million)
Data Table on South America - Market size and forecast 2023-2028 ($ million)
Chart on South America - Year-over-year growth 2023-2028 (%)
Data Table on South America - Year-over-year growth 2023-2028 (%)
8.7 Middle East and Africa - Market size and forecast 2023-2028
Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ million)
Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ million)
Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
8.8 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.10 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.11 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
8.12 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.13 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.14 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 AA Pharma Inc.
AA Pharma Inc. - Overview
AA Pharma Inc. - Product / Service
AA Pharma Inc. - Key offerings
11.4 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
11.5 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.6 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.7 Lexine Technochem Pvt. Ltd.
Lexine Technochem Pvt. Ltd. - Overview
Lexine Technochem Pvt. Ltd. - Product / Service
Lexine Technochem Pvt. Ltd. - Key offerings
11.8 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.9 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.10 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
11.11 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
11.12 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Formulation
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Sulphonamides Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Formulation Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Formulation - Market share 2023-2028 (%)
Exhibits 31: Data Table on Formulation - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Formulation
Exhibits 33: Data Table on Comparison by Formulation
Exhibits 34: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Topical - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Topical - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Topical - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Formulation ($ million)
Exhibits 43: Data Table on Market opportunity by Formulation ($ million)
Exhibits 44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 47: Chart on Geographic comparison
Exhibits 48: Data Table on Geographic comparison
Exhibits 49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on APAC - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on APAC - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on APAC - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on APAC - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on South America - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on South America - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on South America - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on South America - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 93: Market opportunity By Geographical Landscape ($ million)
Exhibits 94: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 95: Impact of drivers and challenges in 2023 and 2028
Exhibits 96: Overview on criticality of inputs and factors of differentiation
Exhibits 97: Overview on factors of disruption
Exhibits 98: Impact of key risks on business
Exhibits 99: Companies covered
Exhibits 100: Matrix on companies position and classification
Exhibits 101: AA Pharma Inc. - Overview
Exhibits 102: AA Pharma Inc. - Product / Service
Exhibits 103: AA Pharma Inc. - Key offerings
Exhibits 104: Abbott Laboratories - Overview
Exhibits 105: Abbott Laboratories - Business segments
Exhibits 106: Abbott Laboratories - Key offerings
Exhibits 107: Abbott Laboratories - Segment focus
Exhibits 108: F. Hoffmann La Roche Ltd. - Overview
Exhibits 109: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 110: F. Hoffmann La Roche Ltd. - Key news
Exhibits 111: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 112: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 113: GlaxoSmithKline Plc - Overview
Exhibits 114: GlaxoSmithKline Plc - Business segments
Exhibits 115: GlaxoSmithKline Plc - Key news
Exhibits 116: GlaxoSmithKline Plc - Key offerings
Exhibits 117: GlaxoSmithKline Plc - Segment focus
Exhibits 118: Lexine Technochem Pvt. Ltd. - Overview
Exhibits 119: Lexine Technochem Pvt. Ltd. - Product / Service
Exhibits 120: Lexine Technochem Pvt. Ltd. - Key offerings
Exhibits 121: Novartis AG - Overview
Exhibits 122: Novartis AG - Business segments
Exhibits 123: Novartis AG - Key news
Exhibits 124: Novartis AG - Key offerings
Exhibits 125: Novartis AG - Segment focus
Exhibits 126: Pfizer Inc. - Overview
Exhibits 127: Pfizer Inc. - Product / Service
Exhibits 128: Pfizer Inc. - Key news
Exhibits 129: Pfizer Inc. - Key offerings
Exhibits 130: Sanofi SA - Overview
Exhibits 131: Sanofi SA - Business segments
Exhibits 132: Sanofi SA - Key news
Exhibits 133: Sanofi SA - Key offerings
Exhibits 134: Sanofi SA - Segment focus
Exhibits 135: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 136: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 137: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 138: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 139: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 140: Viatris Inc. - Overview
Exhibits 141: Viatris Inc. - Business segments
Exhibits 142: Viatris Inc. - Key news
Exhibits 143: Viatris Inc. - Key offerings
Exhibits 144: Viatris Inc. - Segment focus
Exhibits 145: Inclusions checklist
Exhibits 146: Exclusions checklist
Exhibits 147: Currency conversion rates for US$
Exhibits 148: Research methodology
Exhibits 149: Information sources
Exhibits 150: Data validation
Exhibits 151: Validation techniques employed for market sizing
Exhibits 152: Data synthesis
Exhibits 153: 360 degree market analysis
Exhibits 154: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global sulphonamides market: AA Pharma Inc., Abbott Laboratories, Agron Remedies Pvt. Ltd., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Cipla Inc., Dhanuka Agritech Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lexine Technochem Pvt. Ltd., Novartis AG, PANPHARMA S.A., Pfizer Inc., Sanofi SA, Smilax Laboratories Ltd., Stedman Pharmaceuticals Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing awareness of various diseases and their treatment."

According to the report, one of the major drivers for this market is the rising prevalence of infectious diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AA Pharma Inc.
  • Abbott Laboratories
  • Agron Remedies Pvt. Ltd.
  • Amneal Pharmaceuticals Inc.
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Ltd.
  • Cipla Inc.
  • Dhanuka Agritech Ltd.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Lexine Technochem Pvt. Ltd.
  • Novartis AG
  • PANPHARMA S.A.
  • Pfizer Inc.
  • Sanofi SA
  • Smilax Laboratories Ltd.
  • Stedman Pharmaceuticals Pvt. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.